What Parents Need to Know About Screening for Cystic Fibrosis in Newborns
Clinical Scorecard: Essential Information for Parents Regarding Newborn Cystic Fibrosis Screening
At a Glance
| Category | Detail |
|---|
| Condition | Cystic Fibrosis |
| Key Mechanisms | Genetic condition affecting salt absorption, leading to lung and digestive issues. |
| Target Population | Newborns undergoing screening for cystic fibrosis. |
| Care Setting | Newborn screening programs and pediatric care. |
Key Highlights
- Cystic fibrosis screening is part of every state's newborn screening.
- Positive screening does not confirm CF; further genetic testing is required.
- Two CF variants are necessary for a diagnosis of cystic fibrosis.
- Sweat testing measures salt content to confirm CF diagnosis.
Guideline-Based Recommendations
Diagnosis
- Follow up positive newborn screening with genetic testing for CF variants.
- Conduct sweat testing if 1 or 2 CF variants are found.
Management
- Refer to a pediatric pulmonologist if CF is confirmed.
Monitoring & Follow-up
- Regular follow-up with pediatric specialists to monitor lung health and growth.
Risks
- CF can lead to long-lasting lung problems, difficulty gaining weight, and early mortality.
Patient & Prescribing Data
Infants diagnosed with cystic fibrosis.
Modulator medications are available but are not a cure.
Clinical Best Practices
- Collaborate with families to understand screening results and next steps.
- Ensure timely referral to specialized care for confirmed CF cases.
Related Resources & Content
